TP53 and hepatocellular carcinoma: As shown in the networks of arsenic trioxide-target-pathway-HCC and core pathway-target, nodes of AKT1, RAF1, TP53, and PTEN have a higher degree, indicating that they might be the key targets of arsenic trioxide for HCC therapy.